Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations.
Moiseev, Ivan S
Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations. [electronic resource] - European journal of haematology May 2018 - 395-402 p. digital
Publication Type: Journal Article
1600-0609
10.1111/ejh.13030 doi
Adolescent
Adult
Cyclophosphamide--therapeutic use
Female
Graft Survival
Graft vs Host Disease--diagnosis
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Immunosuppressive Agents--therapeutic use
Kaplan-Meier Estimate
Male
Middle Aged
Postoperative Care
Premedication
Tissue Donors
Transplantation Conditioning--adverse effects
Transplantation, Haploidentical
Transplantation, Homologous
Treatment Outcome
Young Adult
Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations. [electronic resource] - European journal of haematology May 2018 - 395-402 p. digital
Publication Type: Journal Article
1600-0609
10.1111/ejh.13030 doi
Adolescent
Adult
Cyclophosphamide--therapeutic use
Female
Graft Survival
Graft vs Host Disease--diagnosis
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Immunosuppressive Agents--therapeutic use
Kaplan-Meier Estimate
Male
Middle Aged
Postoperative Care
Premedication
Tissue Donors
Transplantation Conditioning--adverse effects
Transplantation, Haploidentical
Transplantation, Homologous
Treatment Outcome
Young Adult